Fertin Pharma gains major order for the US market  

2005.01.25
The Jutland based medical chewing gum manufacturer has gained a contract with the US medical distributor Perrigo for nicotine chewing gum

Fertin Pharma in Vejle, Jutland has gained a contract with the US medical distributor Perrigo for nicotine chewing gum. Perrigo supplies over-the-counter drugs to US supermarkets which then sell the products as own label. Perrigo produces some products itself while others are bought from sub-suppliers such as Fertin Pharma. With the introduction of its nicotine chewing gum on the US market, aided by growing sales in Europe, Fertin Pharma's revenues are forecast to grow by more than 50% from DKK 160 mn (USD 28.8 mn) in 2004 to DKK 160 mn (USD 45 mn) in 2005. The news is reported by daily financial newspaper Børsen.

 

Fertin Pharma is a world leader in the development and manufacture of medical chewing gum. The company’s core competence is the controlled release of active substances from gum-based products. It works in partnership with some of the world’s largest pharmaceutical companies such as Novartis and GlaxoSmithKline. Fertin Pharma operates purely as a business-to-business drug delivery company and partner companies hold all marketing rights.

 

Link > Fertin Pharma

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×